Sabah Shah
Ophthalmology · Slingerlands, NYNPI 1588983175
Payments from drug & device makers
Across 286 payments — averaging $154.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$13K
- Genentech USA, Inc.$11K
- AbbVie$6K
- Regeneron Healthcare Solutions, Inc.$5K
- Eyepoint US, Inc.$3K
- Mallinckrodt Hospital Products Inc.$2K
- plus $4K from 20 others
What the payments were for
- Consulting fees$32,48173%
- Speaking & faculty fees$1,3393%
- Travel & lodging$1,7374%
- Food & beverage$8,58519%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 8 | $12,833 |
| Genentech USA, Inc. | 47 | $11,017 |
| AbbVie(2 entities) | 33 | $6,462 |
| Regeneron Healthcare Solutions, Inc. | 52 | $4,862 |
| Eyepoint US, Inc. | 7 | $3,452 |
| Mallinckrodt Hospital Products Inc. | 51 | $1,593 |
| Alimera Sciences, Inc. | 9 | $1,452 |
| Astellas Pharma US Inc | 13 | $449 |
| Bausch & Lomb Americas Inc. | 16 | $346 |
| ANI Pharmaceuticals, Inc. | 13 | $314 |
| Apellis Pharmaceuticals, Inc. | 12 | $276 |
| Oculus Surgical Inc. | 2 | $183 |
| Teva Pharmaceuticals USA, Inc. | 1 | $167 |
| Notal Vision, Inc. | 2 | $139 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $124 |
| Mallinckrodt Enterprises LLC | 1 | $119 |
| Dompe US, Inc. | 4 | $118 |
| Oyster Point Pharma, Inc. | 3 | $77 |
| Harrow Eye, LLC | 2 | $58 |
| Biotissue Holdings Inc. | 1 | $42 |
| Alcon | 2 | $40 |
| Sun Pharmaceutical Industries Inc. | 2 | $30 |
| Tarsus Pharmaceuticals, Inc. | 1 | $28 |
| Abbott | 1 | $23 |
| Carl Zeiss Meditec USA, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,239 in reported general payments places this provider in the 90th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bromfenac Sodium | 34 | $5,602 |
| ProlensaBromfenac Sodium | 14 | $5,568 |
| Difluprednate | 41 | $5,022 |
| Prednisolone Acetate | 49 | $1,439 |
| Loteprednol Etabonate | 12 | $1,344 |
| Ketorolac Tromethamine | 23 | $732 |
| Atropine Sulfate | 20 | $649 |
| Brimonidine Tartrate | 12 | $559 |
| Ofloxacin | 32 | $316 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 20 | $266 |
| Latanoprost | 39 | $257 |
| ErythromycinErythromycin Base | 12 | $93 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Slingerlands
- Steven SimmonsSlingerlands$446K
- Robert SchultzeSlingerlands$153K
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Philip FerroneGreat Neck$5.8M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Glenn StollerRockville Centre$2.1M
- Richard SpaideNew York$1.7M
- Paul HartmanRochester$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.